| Application number | Title of the application | Filing Date | Status |
|---|
| 09/381214 | DIFLUORONUCLEOSIDE PHOSPHONIC ACIDS AND DERIVATIVES THEREOF | Sep 15, 1999 | Abandoned |
Array
(
[id] => 6598442
[patent_doc_number] => 20020042391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'GEMCITABINE DERIVATIVES'
[patent_app_type] => new
[patent_app_number] => 09/355112
[patent_app_country] => US
[patent_app_date] => 1999-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4126
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042391.pdf
[firstpage_image] =>[orig_patent_app_number] => 09355112
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/355112 | Gemcitabine derivatives | Sep 14, 1999 | Issued |
Array
(
[id] => 4422178
[patent_doc_number] => 06177559
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-23
[patent_title] => 'Process for separation of polynucleotide fragments'
[patent_app_type] => 1
[patent_app_number] => 9/391963
[patent_app_country] => US
[patent_app_date] => 1999-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5838
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/177/06177559.pdf
[firstpage_image] =>[orig_patent_app_number] => 391963
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/391963 | Process for separation of polynucleotide fragments | Sep 7, 1999 | Issued |
Array
(
[id] => 1495407
[patent_doc_number] => 06403565
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-11
[patent_title] => 'Antimutagenic compositions for treatment and prevention of photodamage to skin'
[patent_app_type] => B1
[patent_app_number] => 09/387523
[patent_app_country] => US
[patent_app_date] => 1999-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11223
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/403/06403565.pdf
[firstpage_image] =>[orig_patent_app_number] => 09387523
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/387523 | Antimutagenic compositions for treatment and prevention of photodamage to skin | Aug 31, 1999 | Issued |
Array
(
[id] => 4126793
[patent_doc_number] => 06127348
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-03
[patent_title] => 'Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers'
[patent_app_type] => 1
[patent_app_number] => 9/388825
[patent_app_country] => US
[patent_app_date] => 1999-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 13139
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/127/06127348.pdf
[firstpage_image] =>[orig_patent_app_number] => 388825
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/388825 | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers | Aug 31, 1999 | Issued |
Array
(
[id] => 1446821
[patent_doc_number] => 06369040
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Pyrimidine nucleosides'
[patent_app_type] => B1
[patent_app_number] => 09/384826
[patent_app_country] => US
[patent_app_date] => 1999-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9244
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 433
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/369/06369040.pdf
[firstpage_image] =>[orig_patent_app_number] => 09384826
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/384826 | Pyrimidine nucleosides | Aug 26, 1999 | Issued |
Array
(
[id] => 7645448
[patent_doc_number] => 06472522
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-29
[patent_title] => 'Purification of oligomers using dual-end selection'
[patent_app_type] => B1
[patent_app_number] => 09/384852
[patent_app_country] => US
[patent_app_date] => 1999-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14970
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472522.pdf
[firstpage_image] =>[orig_patent_app_number] => 09384852
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/384852 | Purification of oligomers using dual-end selection | Aug 26, 1999 | Issued |
| 09/297640 | MODIFIED NUCLEOSIDE-5'-TRIPHOSPHATES | Aug 26, 1999 | Abandoned |
Array
(
[id] => 4411807
[patent_doc_number] => 06265558
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Thiol-derivatized nucleosides and oligonucleosides'
[patent_app_type] => 1
[patent_app_number] => 9/383856
[patent_app_country] => US
[patent_app_date] => 1999-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10784
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265558.pdf
[firstpage_image] =>[orig_patent_app_number] => 383856
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/383856 | Thiol-derivatized nucleosides and oligonucleosides | Aug 25, 1999 | Issued |
Array
(
[id] => 1459064
[patent_doc_number] => 06426337
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-30
[patent_title] => '2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/331526
[patent_app_country] => US
[patent_app_date] => 1999-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30943
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/426/06426337.pdf
[firstpage_image] =>[orig_patent_app_number] => 09331526
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/331526 | 2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives | Aug 19, 1999 | Issued |
Array
(
[id] => 1507794
[patent_doc_number] => 06440946
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Multiple-agents-binding compound, production and use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/370543
[patent_app_country] => US
[patent_app_date] => 1999-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10652
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440946.pdf
[firstpage_image] =>[orig_patent_app_number] => 09370543
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/370543 | Multiple-agents-binding compound, production and use thereof | Aug 8, 1999 | Issued |
| 09/171429 | PHOSPHATE MIMICS | Aug 2, 1999 | Abandoned |
Array
(
[id] => 1473111
[patent_doc_number] => 06387361
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Use for drug acarbose precose for weight control prevention of weight gain for weight loss for treatment and prevention of obesity'
[patent_app_type] => B1
[patent_app_number] => 09/364992
[patent_app_country] => US
[patent_app_date] => 1999-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 511
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387361.pdf
[firstpage_image] =>[orig_patent_app_number] => 09364992
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/364992 | Use for drug acarbose precose for weight control prevention of weight gain for weight loss for treatment and prevention of obesity | Aug 1, 1999 | Issued |
Array
(
[id] => 1560827
[patent_doc_number] => 06437117
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Synthesis, deprotection, analysis and purification for RNA and ribozymes'
[patent_app_type] => B1
[patent_app_number] => 09/363238
[patent_app_country] => US
[patent_app_date] => 1999-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12082
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/437/06437117.pdf
[firstpage_image] =>[orig_patent_app_number] => 09363238
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/363238 | Synthesis, deprotection, analysis and purification for RNA and ribozymes | Jul 26, 1999 | Issued |
Array
(
[id] => 1468092
[patent_doc_number] => 06458983
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide-base modifiers'
[patent_app_type] => B1
[patent_app_number] => 09/357974
[patent_app_country] => US
[patent_app_date] => 1999-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3011
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458983.pdf
[firstpage_image] =>[orig_patent_app_number] => 09357974
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/357974 | Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide-base modifiers | Jul 20, 1999 | Issued |
Array
(
[id] => 4356086
[patent_doc_number] => 06291669
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Solid phase synthesis'
[patent_app_type] => 1
[patent_app_number] => 9/254048
[patent_app_country] => US
[patent_app_date] => 1999-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5387
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291669.pdf
[firstpage_image] =>[orig_patent_app_number] => 254048
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254048 | Solid phase synthesis | Jul 18, 1999 | Issued |
Array
(
[id] => 1507785
[patent_doc_number] => 06440943
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages'
[patent_app_type] => B1
[patent_app_number] => 09/352058
[patent_app_country] => US
[patent_app_date] => 1999-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23511
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440943.pdf
[firstpage_image] =>[orig_patent_app_number] => 09352058
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/352058 | Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages | Jul 13, 1999 | Issued |
| 09/341365 | PURIFICATION AND/OR CONCENTRATION OF DNA BY CROSS-FLOW FILTRATION, SEPARATION OF ENDOTOXINS FROM A NUCLEIC ACID PREPARATION | Jul 8, 1999 | Abandoned |
Array
(
[id] => 1521754
[patent_doc_number] => 06414135
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'C3-methylene hydrogen phosphonate monomers and related compounds'
[patent_app_type] => B1
[patent_app_number] => 09/349035
[patent_app_country] => US
[patent_app_date] => 1999-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 25248
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 463
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/414/06414135.pdf
[firstpage_image] =>[orig_patent_app_number] => 09349035
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/349035 | C3-methylene hydrogen phosphonate monomers and related compounds | Jul 6, 1999 | Issued |
Array
(
[id] => 4383081
[patent_doc_number] => 06277830
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => '5\'-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon'
[patent_app_type] => 1
[patent_app_number] => 9/348534
[patent_app_country] => US
[patent_app_date] => 1999-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6678
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277830.pdf
[firstpage_image] =>[orig_patent_app_number] => 348534
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/348534 | 5'-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon | Jul 6, 1999 | Issued |